V S Tompkins
Overview
Explore the profile of V S Tompkins including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
95
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tompkins V, Valverde D, Moss W
BMC Res Notes
. 2018 Feb;
11(1):139.
PMID: 29458410
Objective: The function of Epstein-Barr virus (EBV) stable intronic sequence (sis)RNAs, non-coding RNAs transcribed from a region required for EBV-mediated cellular transformation, remain unknown. To better understand the function of...
2.
Tompkins V, Sompallae R, Rosean T, Walsh S, Acevedo M, Kovalchuk A, et al.
Blood Cancer J
. 2016 Nov;
6(11):e488.
PMID: 27813533
Waldenström macroglobulinemia (WM) is a low-grade incurable immunoglobulin M (IgM) lymphoplasmacytic lymphoma for which a genetically engineered mouse model of de novo tumor development is lacking. On the basis of...
3.
Rosean T, Holman C, Tompkins V, Jing X, Krasowski M, Rose-John S, et al.
Blood Cancer J
. 2016 Feb;
6:e398.
PMID: 26918362
No abstract available.
4.
Gu C, Yang Y, Sompallae R, Xu H, Tompkins V, Holman C, et al.
Leukemia
. 2015 Dec;
30(4):873-82.
PMID: 26648534
The transcription factor forkhead box M1 (FOXM1) is a validated oncoprotein in solid cancers, but its role in malignant plasma cell tumors such as multiple myeloma (MM) is unknown. We...
5.
Tompkins V, Rosean T, Holman C, DeHoedt C, Olivier A, Duncan K, et al.
Leukemia
. 2015 Jul;
30(4):962-6.
PMID: 26202932
No abstract available.
6.
Rosean T, Tompkins V, Olivier A, Sompallae R, Norian L, Morse 3rd H, et al.
Leukemia
. 2014 Sep;
29(1):233-7.
PMID: 25257990
No abstract available.
7.
Duncan K, Rosean T, Tompkins V, Olivier A, Sompallae R, Zhan F, et al.
Blood Cancer J
. 2013 Dec;
3:e165.
PMID: 24292417
(18)F-fluorodeoxyglucose positron emission tomography (FDG-PET) and computed tomography (CT) are useful imaging modalities for evaluating tumor progression and treatment responses in genetically engineered mouse models of solid human cancers, but...